ISRCTN14881129已完成Unknown
A randomized, single-blind, placebo-controlled study assessing the acute effects of hibiscus sabdariffa on cardiometabolic markers and cognitive function in metabolically challenged individuals
niversity of Leeds0 个研究点目标入组 20 人开始时间: 2024年6月20日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 18-56
- •2. BMI more than 27kg/m2 but less than35kg/m2
- •3. Male and female, local to the Leeds area
- •4. Presence of high blood pressure
- •5. Sufficient knowledge and understanding of the English language (preferably first language)
排除标准
- •1. For women – pregnancy, lactation, perimenopause/menopause
- •2. Food allergy or intolerance to any of the study foods
- •3. Medical conditions – clinical depression, thyroid diseases, hypertension, type 1 or type 2 diabetes, or blood diseases
- •4. Using any medication for hypertension or cholesterol-lowering sterols
- •5. Recent blood donation (<3 months)
- •6. Participation in simultaneous studies
研究者
相似试验
进行中（未招募）
1 期
Evaluation of Efficacy and Safety of Sarilumab in Patients with GCAGiant Cell ArteritisEUCTR2017-002988-18-SESanofi-Aventis Recherche & Développement508
进行中（未招募）
不适用
A clinical study to evaluate the efficacy and tolerability of a novel herbal composition to relieve constipation and to improve bowel clearanceCTRI/2022/09/046036Bohan and Co
进行中（未招募）
1 期
Evaluation of the Efficacy and Safety of Sarilumab in Patients with Polymyalgia RheumaticaPolymyalgia rheumaticaEUCTR2017-002989-42-DKSanofi-Aventis Recherche & Développement500
进行中（未招募）
1 期
Evaluation of Efficacy and Safety of Sarilumab in Patients with GCAGiant Cell ArteritisEUCTR2017-002988-18-DKSanofi-Aventis Recherche & Développement508
进行中（未招募）
不适用
A randomized, double-blind, placebo-controlled study to evaluate the safety of 12 weeks of dosing with GW856553 and its effects on inflammatory markers, infarct size, and cardiac function in subjects with myocardial infarction without STsegmentelevation - SOLSTICESubjects with myocardial infarction without ST-segment elevationMedDRA version: 9.1Level: LLTClassification code 10064347Term: Non ST segment elevation myocardial infarctionEUCTR2009-010615-32-NLGlaxoSmithKline R&D Ltd400